EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

New treatment for antibody-mediated rejection: interleukin-6 inhibitors

Byung Hwa Park iD, Ye Na Kim iD, Ho Sik Shin iD

Clinical Transplantation and Research · 2024

DOI: 10.4285/ctr.23.0069 ↗

At a glance

Übersichtsarbeit in Clinical Transplantation and Research, 2024. Written by Byung Hwa Park and 2 co-authors. Institution: Division of Nephrology, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea. Cited 4 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Korean Society for Transplantation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

AntibodyInterleukin-6Kidney transplantationRejection

Authors and institutions

  • Division of Nephrology, Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
  • Transplantation Research Institute, Kosin University College of Medicine, Busan, Korea.

ORCID profiles: Byung Hwa Park, Ye Na Kim, Ho Sik Shin

Funding

  • Korean Society for Transplantation

Cite

APA

Park, B. H., Kim, Y. N., & Shin, H. S. (2024). New treatment for antibody-mediated rejection: interleukin-6 inhibitors. Clinical Transplantation and Research. https://doi.org/10.4285/ctr.23.0069

Vancouver

Park BH, Kim YN, Shin HS. New treatment for antibody-mediated rejection: interleukin-6 inhibitors. Clinical Transplantation and Research. 2024. doi:10.4285/ctr.23.0069

BibTeX
@article{Park2024,
  author = {Park, Byung Hwa and Kim, Ye Na and Shin, Ho Sik},
  title = {New treatment for antibody-mediated rejection: interleukin-6 inhibitors},
  journal = {Clinical Transplantation and Research},
  year = {2024},
  doi = {10.4285/ctr.23.0069}
}
Start for free →